Discover 1,437 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,437
Active & Responsive
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: San Antonio TX, Houston TX, Nashville TN,
Sponsor: Ipsen
Sex: All
Age: 18+
Code: NCT07213830
Phase 1, Phase 2, Recruiting
Active & ResponsiveNew
JUR-003 in Adult Patients With Metastatic Prostate Cancer
for
Metastatic Castration Resistant Prostate Cancer,
Location: San Antonio TX, Nashville TN, Grand Rapids MI,
Location: San Antonio TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT05786924
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: San Antonio TX, Bellaire TX, Dallas TX, Lake Charles LA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: San Antonio TX, Fort Worth TX, Dallas TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: San Antonio TX, Austin TX, Webster TX, Abilene TX,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: San Antonio TX, Houston TX, Dallas TX, El Paso TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension